Company Filing History:

12 out of 677

Eisai Company, Limited

where one patent can have more than one assignee

Years Active: 1988-1997

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5668136 - Trisubstituted benzene derivatives, composition and methods of treatment (1997-09-16),

2. 5206403 - Diphenylethylene derivatives, pharmaceutical compositions containing (1993-04-27),

3. 5182301 - Diphenylethylene derivatives pharmaceutical compositions containing same (1993-01-26),

4. 5103010 - Diphenylethylene derivatives, pharmaceutical compositions containing (1992-04-07),

5. 5064848 - Benzophenone oxime ether compounds, pharmaceutical compositions and (1991-11-12),

6. 5034418 - Diphenylethylene derivatives, pharmaceutical compositions containing (1991-07-23),

7. 4992469 - Method of obtaining an antiplatelet effect (1991-02-12),

8. 4978767 - Diphenylethylene derivative and pharmaceutical use (1990-12-18),

9. 4954523 - Benzophenone oxime ether compounds, pharmaceutical compositions and (1990-09-04),

10. 4886834 - Diphenyl-methane compounds useful in the treatment of diseases caused by (1989-12-12),

11. 4762829 - Polyprenyl compound, process for the production thereof and drug (1988-08-09),

12. 4742058 - Polyprenyl compound, process for the production thereof and drug (1988-05-03),

Title: Tohru Fujimori: Innovator in Pharmaceutical Chemistry

Introduction

Tohru Fujimori is a prominent inventor based in Toyosato, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 12 patents. His work focuses on developing novel compounds that have therapeutic applications, particularly in treating cardiovascular diseases.

Latest Patents

Fujimori's latest patents include innovative compounds such as trisubstituted benzene derivatives. These compounds are recognized for their potential as anti-arteriosclerotic agents. The specific formula involves various substituents that enhance the compound's efficacy. Another notable patent involves diphenylethylene derivatives, which are useful in inhibiting blood agglomeration. These compounds are defined by specific chemical structures that include diphenyl-methane derivatives and benzophenone oxime derivatives.

Career Highlights

Throughout his career, Tohru Fujimori has worked with esteemed organizations such as Eisai Company, Limited and Nagoya University. His research has led to advancements in drug development, particularly in the area of cardiovascular health. His innovative approach to pharmaceutical chemistry has garnered attention in the scientific community.

Collaborations

Fujimori has collaborated with notable colleagues, including Shinya Abe and Isao Yamatsu. These partnerships have contributed to the success of his research and the development of new pharmaceutical compounds.

Conclusion

Tohru Fujimori's contributions to pharmaceutical chemistry are significant, with a focus on developing innovative compounds for treating cardiovascular diseases. His work continues to impact the field and offers promising avenues for future research and development.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com